Temporal Bone Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Temporal Bone Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study (NCT05444673) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-06-01 |
Track Temporal Bone Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.